This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Douglas W McMillin: Innovator in Cancer Treatment
Introduction
Douglas W McMillin is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of medicine, particularly in cancer treatment. His innovative approach focuses on the use of reversine and its analogs to combat cancer effectively.
Latest Patents
Douglas W McMillin holds a patent for the "Use of reversine and analogs for treatment of cancer." This patent outlines methods and compositions for treating cancer. In one embodiment, the method involves administering an effective amount of reversine, reversine analog, or reversine-containing agent to a patient suffering from cancer. Additionally, the patent provides compositions that may include reversine along with other active agents and additives. These methods and compositions are particularly useful in the medical field.
Career Highlights
McMillin is associated with the Dana-Farber Cancer Institute Inc., where he continues to work on innovative solutions for cancer treatment. His dedication to research and development in this area has positioned him as a key figure in the fight against cancer.
Collaborations
Some of his notable coworkers include Constantine S Mitsiades and Kenneth Carl Anderson. Their collaborative efforts contribute to advancing cancer research and treatment methodologies.
Conclusion
Douglas W McMillin's work exemplifies the impact of innovation in medicine, particularly in cancer treatment. His patent and ongoing research efforts highlight the importance of developing effective therapies for patients.